|TOP PICK||$69.420||SELECTIVE||NORTH AMERICAN - LARGE||Yes|
2.9% dividend. Going down the path into splitting into two businesses. The pharma business has a higher than industry growth rate. Best performing sector in the market at present. The patent cliff is here and priced into the stock price.
President & Chief Investment Strategist, Barometer Capital Management